T. Adayev, M. Chen-hwang, N. Murakami, R. Wang, and H. , , 2006.

, MNB/DYRK1A phosphorylation regulates the interactions of synaptojanin 1 with endocytic accessory proteins, Biochem. Biophys. Res. Commun, vol.351, pp.1060-1065

M. Y. Ahmed, B. A. Chioza, A. Rajab, K. Schmitz-abe, A. Al-khayat et al., Loss of PCLO function underlies pontocerebellar hypoplasia type III, Neurology, vol.84, issue.17, p.1745, 2015.
DOI : 10.1212/WNL.0000000000001523

K. Ahn, H. K. Jeong, H. Choi, S. Ryoo, Y. J. Kim et al., DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects, Neurobiology of Disease, vol.22, issue.3, pp.463-472, 2006.
DOI : 10.1016/j.nbd.2005.12.006

M. M. Airaksinen, A. Lecklin, V. Saano, L. Tuomisto, and J. Gynther, Tremorigenic Effect and Inhibition of Tryptamine and Serotonin Receptor Binding by ??-Carbolines, Pharmacology & Toxicology, vol.7, issue.1, pp.5-8, 1987.
DOI : 10.1111/j.1600-0773.1982.tb01030.x

A. Aksoy-aksel and D. Manahan-vaughan, The temporoammonic input to the hippocampal CA1 region displays distinctly different synaptic plasticity compared to the Schaffer collateral input in vivo: significance for synaptic information processing, Frontiers in Synaptic Neuroscience, vol.5, 2013.
DOI : 10.3389/fnsyn.2013.00005

M. M. Albasser, G. L. Poirier, and J. P. And-aggleton, Qualitatively different modes of perirhinal??????hippocampal engagement when rats explore novel vs. familiar objects as revealed by c-Fos imaging, European Journal of Neuroscience, vol.9, issue.1, pp.134-147, 2010.
DOI : 10.1038/jcbfm.1993.4

R. Albores, E. J. Neafsey, G. Drucker, J. Z. Fields, C. et al., Mitochondrial respiratory inhibition by N-methylated beta-carboline derivatives structurally resembling N-methyl-4-phenylpyridine., Proceedings of the National Academy of Sciences, vol.87, issue.23, p.9368, 1990.
DOI : 10.1073/pnas.87.23.9368

S. Ally, A. L. Jolly, G. , and V. I. , Motor-cargo release: CaMKII as a traffic cop, Nature Cell Biology, vol.8, issue.1, pp.3-5, 2008.
DOI : 10.1111/j.1600-0854.2006.00482.x

X. Altafaj, M. Dierssen, C. Baamonde, E. Martí, J. Visa et al., Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome, Human Molecular Genetics, vol.10, issue.18, pp.1915-1923, 2001.
DOI : 10.1093/hmg/10.18.1915

X. Altafaj, E. D. Martín, J. Ortiz-abalia, A. Valderrama, C. Lao-peregrín et al., Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome, Neurobiology of Disease, vol.52, pp.117-127, 2013.
DOI : 10.1016/j.nbd.2012.11.017

M. Alvarez, X. Altafaj, S. Aranda, L. , and S. De-la, DYRK1A Autophosphorylation on Serine Residue 520 Modulates Its Kinase Activity via, pp.14-17, 2007.

, Binding. Mol. Biol. Cell, vol.18, pp.1167-1178

Y. Andrade-talavera, I. Benito, J. J. Casañas, A. Rodríguez-moreno, and M. L. Montesinos, Rapamycin restores BDNF-LTP and the persistence of long-term memory in a model of Down's syndrome, Neurobiology of Disease, vol.82, pp.516-525, 2015.
DOI : 10.1016/j.nbd.2015.09.005

S. E. Antonarakis, R. Lyle, E. T. Dermitzakis, A. Reymond, and S. Deutsch, , 2004.

, Chromosome 21 and Down syndrome: from genomics to pathophysiology, Nat. Rev. Genet, vol.5, pp.725-738

S. Aranda, A. Laguna, L. , and S. De-la, DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles, The FASEB Journal, vol.29, issue.2, pp.449-462, 2011.
DOI : 10.1074/jbc.M707358200

G. Arqué, V. Fotaki, D. Fernández, M. M. Lagrán, . De et al., Impaired Spatial Learning Strategies and Novel Object Recognition in Mice Haploinsufficient for the Dual Specificity Tyrosine-Regulated Kinase-1A (Dyrk1A), PLoS ONE, vol.58, issue.7, 2008.
DOI : 10.1371/journal.pone.0002575.s001

J. R. Arron, M. M. Winslow, A. Polleri, C. Chang, H. Wu et al., NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21, Nature, vol.100, issue.Suppl., pp.595-600, 2006.
DOI : 10.1073/pnas.1432926100

E. H. Aylward, Q. Li, N. A. Honeycutt, A. C. Warren, M. B. Pulsifer et al., MRI Volumes of the Hippocampus and Amygdala in Adults With Down's Syndrome With and Without Dementia, Am. J. Psychiatry, 1999.

A. Baddeley, Working memory, Current Biology, vol.20, issue.4, pp.136-140, 2010.
DOI : 10.1016/j.cub.2009.12.014

A. Baddeley and C. Jarrold, Working memory and Down syndrome, Journal of Intellectual Disability Research, vol.39, issue.12, pp.925-931, 2007.
DOI : 10.1080/01688639408402641

J. Bain, L. Plater, M. Elliott, N. Shpiro, C. J. Hastie et al., The selectivity of protein kinase inhibitors: a further update, Biochemical Journal, vol.408, issue.3, pp.297-315, 2007.
DOI : 10.1042/BJ20070797
URL : https://hal.archives-ouvertes.fr/hal-00478827

G. M. Barlow, X. Chen, Z. Y. Shi, G. E. Lyons, D. M. Kurnit et al., Down syndrome congenital heart disease: A narrowed region and a candidate gene, Genetics in Medicine, vol.18, issue.2, pp.91-101, 2001.
DOI : 10.1016/S0896-6273(00)80264-0

L. L. Baxter, T. H. Moran, J. T. Richtsmeier, J. Troncoso, and R. H. Reeves, , 2000.

, Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse, Hum. Mol. Genet, vol.9, pp.195-202

P. V. Belichenko, E. Masliah, A. M. Kleschevnikov, A. J. Villar, C. J. Epstein et al., Synaptic structural abnormalities in the Ts65Dn mouse model of down syndrome, The Journal of Comparative Neurology, vol.24, issue.3, pp.281-298, 2004.
DOI : 10.1212/WNL.34.7.909

P. V. Belichenko, A. M. Kleschevnikov, A. Salehi, C. J. Epstein, and W. C. Mobley, , 2007.

, Synaptic and cognitive abnormalities in mouse models of down syndrome: Exploring genotype?phenotype relationships, J. Comp. Neurol, vol.504, pp.329-345

R. Benavides-piccione, M. Dierssen, I. Ballesteros-yáñez, M. Martínez-de-lagrán, M. L. Arbonés et al., Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A+/??? mouse, Neurobiology of Disease, vol.20, issue.1, pp.115-122, 2005.
DOI : 10.1016/j.nbd.2005.02.004

F. Benfenati, F. Valtorta, and P. Greengard, Computer modeling of synapsin I binding to synaptic vesicles and F-actin: implications for regulation of neurotransmitter release., Proc. Natl. Acad. Sci, pp.575-579, 1991.
DOI : 10.1073/pnas.88.2.575

F. Benfenati, F. Valtorta, J. L. Rubenstein, F. S. Gorelick, P. Greengard et al., Synaptic vesicle-associated Ca2+/calmodulin-dependent protein kinase II is a binding protein for synapsin I, Nature, vol.359, issue.6394, pp.417-420, 1992.
DOI : 10.1038/359417a0

L. Book, A. Hart, J. Black, M. Feolo, J. J. Zone et al., Prevalence and clinical characteristics of celiac disease in Downs syndrome in a U.S. study, American Journal of Medical Genetics, vol.6, issue.1, pp.70-74, 2001.
DOI : 10.1002/1096-8628(20010101)98:1<70::AID-AJMG1002>3.0.CO;2-G

E. Borella, B. Carretti, and S. Lanfranchi, Inhibitory mechanisms in Down syndrome: Is there a specific or general deficit?, Research in Developmental Disabilities, vol.34, issue.1, pp.65-71, 2013.
DOI : 10.1016/j.ridd.2012.07.017

D. I. Brierley, D. , and C. , Developments in harmine pharmacology ??? Implications for ayahuasca use and drug-dependence treatment, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.39, issue.2, pp.263-272, 2012.
DOI : 10.1016/j.pnpbp.2012.06.001

N. J. Broadbent, L. R. Squire, C. , and R. E. , Spatial memory, recognition memory, and the hippocampus, Proceedings of the National Academy of Sciences, vol.9, issue.2, pp.14515-14520, 2004.
DOI : 10.1101/lm.46102

E. A. Buffalo, P. S. Bellgowan, and A. Martin, Distinct roles for medial temporal lobe structures in memory for objects and their locations, Learning & Memory, vol.13, issue.5, p.638, 2006.
DOI : 10.1101/lm.251906

M. J. Bull and . Genetics, Health Supervision for Children With Down Syndrome, PEDIATRICS, vol.128, issue.2, pp.393-406, 2011.
DOI : 10.1542/peds.2011-1605

A. Bush and N. Beail, Risk Factors for Dementia in People With Down Syndrome: Issues in Assessment and Diagnosis, American Journal on Mental Retardation, vol.109, issue.2
DOI : 10.1352/0895-8017(2004)109<83:RFFDIP>2.0.CO;2

C. , C. , B. , V. Am, G. et al., , 1996.

, novel 420 kDa protein associated with the presynaptic cytomatrix, Eur. J. Cell Biol, vol.69, pp.214-223

C. , C. Cb, M. Ca, and M. , Early vocabulary acquisition by children with Down syndrome, Am. J. Ment. Defic, vol.90, pp.177-184, 1985.

J. C. Callaway, D. J. Mckenna, C. S. Grob, G. S. Brito, L. P. Raymon et al., Pharmacokinetics of Hoasca alkaloids in healthy humans, Journal of Ethnopharmacology, vol.65, issue.3, pp.243-256, 1999.
DOI : 10.1016/S0378-8741(98)00168-8

M. A. Canfield, M. A. Honein, N. Yuskiv, J. Xing, C. T. Mai et al., National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999???2001, Birth Defects Research Part A: Clinical and Molecular Teratology, vol.151, issue.11, pp.747-756, 1999.
DOI : 10.1001/archpedi.1997.02170480026004

C. B. Canto, F. G. Wouterlood, and M. P. Witter, , 2008.

C. Canzonetta, C. Mulligan, S. Deutsch, S. Ruf, A. O-'doherty et al., DYRK1A-Dosage Imbalance Perturbs NRSF/REST Levels, Deregulating Pluripotency and Embryonic Stem Cell Fate in Down Syndrome, The American Journal of Human Genetics, vol.83, issue.3, pp.388-400, 2008.
DOI : 10.1016/j.ajhg.2008.08.012

G. A. Carlesimo, L. Marotta, and S. Vicari, Long-term memory in mental retardation: Evidence for a specific impairment in subjects with Down's syndrome, Neuropsychologia, vol.35, issue.1, pp.71-79, 1997.
DOI : 10.1016/S0028-3932(96)00055-3

J. Carr, Stability and change in cognitive ability over the life span: a comparison of populations with and without Down's syndrome, Journal of Intellectual Disability Research, vol.89, issue.12, pp.915-928, 2005.
DOI : 10.1093/geronj/34.2.242

S. Catuara-solarz, J. Espinosa-carrasco, I. Erb, K. Langohr, C. Notredame et al., Principal Component Analysis of the Effects of Environmental Enrichment and (-)-epigallocatechin-3-gallate on Age-Associated Learning Deficits in a Mouse Model of Down Syndrome, Frontiers in Behavioral Neuroscience, vol.85, issue.29, 2015.
DOI : 10.2174/1389450116666150825113655

F. Cesca, P. Baldelli, F. Valtorta, and F. Benfenati, The synapsins: Key actors of synapse function and plasticity, Progress in Neurobiology, vol.91, issue.4, pp.313-348, 2010.
DOI : 10.1016/j.pneurobio.2010.04.006

J. Chen, J. Lin, F. Tsai, M. , and T. , Dosage of Dyrk1a Shifts Cells within a p21-Cyclin D1 Signaling Map to Control the Decision to Enter the Cell Cycle, Molecular Cell, vol.52, issue.1, pp.87-100, 2013.
DOI : 10.1016/j.molcel.2013.09.009

R. J. Church, D. M. Gatti, T. J. Urban, N. Long, X. Yang et al., Sensitivity to hepatotoxicity due to epigallocatechin gallate is affected by genetic background in diversity outbred mice, Food and Chemical Toxicology, vol.76, pp.19-26, 2015.
DOI : 10.1016/j.fct.2014.11.008

D. A. Coulter, C. Yue, C. W. Ang, F. Weissinger, E. Goldberg et al., Hippocampal microcircuit dynamics probed using optical imaging approaches, The Journal of Physiology, vol.27, issue.Suppl 7, 1893.
DOI : 10.1523/JNEUROSCI.1555-07.2007

J. Courcet, L. Faivre, P. Malzac, A. Masurel-paulet, E. Lopez et al., gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy, Journal of Medical Genetics, vol.49, issue.12, pp.731-736, 2012.
DOI : 10.1136/jmedgenet-2012-101251

A. L. Creavin and R. D. Brown, Ophthalmic Abnormalities in Children with down Syndrome, Journal of Pediatric Ophthalmology & Strabismus, vol.46, issue.2, pp.76-82, 2009.
DOI : 10.3928/01913913-20090301-06

S. M. Day, D. J. Strauss, R. M. Shavelle, R. , and R. J. , Mortality and causes of death in persons with Down syndrome in California, Developmental Medicine & Child Neurology, vol.359, issue.3, pp.171-176, 2005.
DOI : 10.1093/oxfordjournals.aje.a009084

M. Debdab, F. Carreaux, S. Renault, M. Soundararajan, O. Fedorov et al., Leucettines, a Class of Potent Inhibitors of cdc2-Like Kinases and Dual Specificity, Tyrosine Phosphorylation Regulated Kinases Derived from the Marine Sponge Leucettamine B: Modulation of Alternative Pre- RNA Splicing, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00870007

J. Delabar, J. Blouin, and Z. Rahmani, Molecular Mapping of Twenty-Four Features of Down Syndrome on Chromosome 21, European Journal of Human Genetics, vol.1, issue.2
DOI : 10.1159/000472398

J. Dennis, N. Archer, J. Ellis, and L. Marder, Recognising heart disease in children with Down syndrome, Archives of Disease in Childhood - Education and Practice, vol.95, issue.4, pp.98-104, 2010.
DOI : 10.1136/adc.2007.126672

A. Desai, S. Verma, T. J. Mitchison, and C. E. Walczak, Kin I Kinesins Are Microtubule-Destabilizing Enzymes, Cell, vol.96, issue.1, pp.69-78, 1999.
DOI : 10.1016/S0092-8674(00)80960-5

W. K. Dowjat, T. Adayev, I. Kuchna, K. Nowicki, S. Palminiello et al., Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome, Neuroscience Letters, vol.413, issue.1, pp.77-81, 2007.
DOI : 10.1016/j.neulet.2006.11.026

A. Duchon and Y. Herault, DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome, Frontiers in Behavioral Neuroscience, vol.18, issue.47, 2016.
DOI : 10.1002/ddrr.1128

A. Duchon, M. Raveau, C. Chevalier, V. Nalesso, A. J. Sharp et al., , 2011.

, Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling down syndrome, Mamm. Genome, vol.22, pp.674-684

C. L. Duigou, J. Simonnet, M. T. Teleñczuk, D. Fricker, M. et al., Recurrent synapses and circuits in the CA3 region of the hippocampus: an associative network, Front. Cell. Neurosci, vol.7, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01320073

É. Esquirol and . Esquirol, 1772-1840) (1838) Des maladies mentales : considérées sous les rapports médical, hygiénique et médico-légal

J. Fabia, M. Drolette, . Malformations, . Leukemia, . Children et al., Pediatrics, vol.45, pp.60-70, 1970.

X. Fant, E. Durieu, G. Chicanne, B. Payrastre, D. Sbrissa et al., cdc-Like/Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases Inhibitor Leucettine L41 Induces mTOR-Dependent Autophagy: Implication for Alzheimer's Disease, Molecular Pharmacology, vol.85, issue.3, pp.441-450, 2014.
DOI : 10.1124/mol.113.090837

A. Fassio, L. Patry, S. Congia, F. Onofri, A. Piton et al., SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function, Human Molecular Genetics, vol.106, issue.12, pp.2297-2307, 2011.
DOI : 10.1073/pnas.0910297106

S. D. Fenster, M. M. Kessels, B. Qualmann, W. J. Chung, J. Nash et al., Interactions between Piccolo and the Actin/Dynamin-binding Protein Abp1 Link Vesicle Endocytosis to Presynaptic Active Zones, Journal of Biological Chemistry, vol.1359, issue.22, pp.20268-20277, 2003.
DOI : 10.1016/0896-6273(88)90140-7

K. A. Foster, N. Mclaughlin, D. Edbauer, M. Phillips, A. Bolton et al., Distinct Roles of NR2A and NR2B Cytoplasmic Tails in Long-Term Potentiation, Journal of Neuroscience, vol.30, issue.7, p.2676, 2010.
DOI : 10.1523/JNEUROSCI.4022-09.2010

V. Fotaki, M. Dierssen, S. Alcántara, S. Martínez, E. Martí et al., Dyrk1A Haploinsufficiency Affects Viability and Causes Developmental Delay and Abnormal Brain Morphology in Mice, Molecular and Cellular Biology, vol.22, issue.18, pp.6636-6647, 2002.
DOI : 10.1128/MCB.22.18.6636-6647.2002

S. B. Freeman, L. F. Taft, K. J. Dooley, K. Allran, S. L. Sherman et al., Population-based study of congenital heart defects in Down syndrome, American Journal of Medical Genetics, vol.92, issue.3, pp.213-217, 1998.
DOI : 10.1002/(SICI)1096-8628(19981116)80:3<213::AID-AJMG6>3.0.CO;2-8

T. F. Freund, I. Katona, and D. Piomelli, Role of Endogenous Cannabinoids in Synaptic Signaling, Physiological Reviews, vol.83, issue.3, pp.1017-1066, 2003.
DOI : 10.1038/22761

D. Frost, B. Meechoovet, T. Wang, S. Gately, M. Giorgetti et al., ??-Carboline Compounds, Including Harmine, Inhibit DYRK1A and Tau Phosphorylation at Multiple Alzheimer's Disease-Related Sites, PLoS ONE, vol.103, issue.5, 2011.
DOI : 10.1371/journal.pone.0019264.s002

J. A. Fuentes and V. G. Longo, An investigation on the central effects of harmine, harmaline and related ??-carbolines, Neuropharmacology, vol.10, issue.1, pp.15-23, 1971.
DOI : 10.1016/0028-3908(71)90004-9

C. C. Garcia, H. J. Blair, M. Seager, A. Coulthard, S. Tennant et al., Identification of a mutation in synapsin I, a synaptic vesicle protein, in a family with epilepsy, Journal of Medical Genetics, vol.41, issue.3, pp.183-186, 2004.
DOI : 10.1136/jmg.2003.013680

S. García-cerro, P. Martínez, V. Vidal, A. Corrales, J. Flórez et al., Overexpression of Dyrk1A Is Implicated in Several Cognitive, Electrophysiological and Neuromorphological Alterations Found in a Mouse Model of Down Syndrome, PLoS ONE, vol.29, issue.9, 2014.
DOI : 10.1371/journal.pone.0106572.t002

C. C. Garner, S. Kindler, and E. D. Gundelfinger, Molecular determinants of presynaptic active zones, Current Opinion in Neurobiology, vol.10, issue.3, pp.321-327, 2000.
DOI : 10.1016/S0959-4388(00)00093-3

S. E. Gathercole and A. D. Baddeley, Phonological memory deficits in language disordered children: Is there a causal connection?, Journal of Memory and Language, vol.29, issue.3, pp.336-360, 1990.
DOI : 10.1016/0749-596X(90)90004-J

R. L. Geggel, J. E. O-'brien, and M. Feingold, Development of valve dysfunction in adolescents and young adults with down syndrome and no known congenital heart disease, The Journal of Pediatrics, vol.122, issue.5, pp.821-823, 1993.
DOI : 10.1016/S0022-3476(06)80036-3

S. D. Ginsberg, C. , and S. , Expression profile analysis within the human hippocampus: Comparison of CA1 and CA3 pyramidal neurons, The Journal of Comparative Neurology, vol.441, issue.1, pp.107-118, 2005.
DOI : 10.1007/978-1-4615-6616-8_9

E. Glasson, S. Sullivan, R. Hussain, B. Petterson, P. Montgomery et al., , 2002.

, The changing survival profile of people with Down's syndrome: implications for genetic counselling, Clin. Genet, vol.62, pp.390-393

N. Göckler, G. Jofre, C. Papadopoulos, U. Soppa, F. J. Tejedor et al., , 2009.

, Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation, FEBS J, vol.276, pp.6324-6337

N. Göckler, G. Jofre, C. Papadopoulos, U. Soppa, F. J. Tejedor et al., , 2009.

, Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation, FEBS J, vol.276, pp.6324-6337

N. Göckler, G. Jofre, C. Papadopoulos, U. Soppa, F. J. Tejedor et al., , 2009.

, Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation, FEBS J, vol.276, pp.6324-6337

J. W. Goodliffe, J. L. Olmos-serrano, N. M. Aziz, J. L. Pennings, F. Guedj et al., Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome, Journal of Neuroscience, vol.36, issue.10, pp.2926-2944, 2016.
DOI : 10.1523/JNEUROSCI.2513-15.2016

K. Graaf, . De, H. Czajkowska, S. Rottmann, L. C. Packman et al., The protein kinase DYRK1A phosphorylates the splicing factor SF3b1/SAP155 at Thr434, a novel in vivo phosphorylation site, BMC Biochem, vol.7, issue.7, 2006.

K. Graaf, . De, H. Czajkowska, S. Rottmann, L. C. Packman et al., Cerebral activation related to skills practice in a double serial reaction time task: striatal involvement in random-order sequence learning, Cognitive Brain Research, vol.20, issue.2, pp.120-131, 2004.
DOI : 10.1016/j.cogbrainres.2004.02.003

C. Grau, K. Arató, J. M. Fernández-fernández, A. Valderrama, C. Sindreu et al., DYRK1A-mediated phosphorylation of GluN2A at Ser1048 regulates the surface expression and channel activity of GluN1/GluN2A receptors, Frontiers in Cellular Neuroscience, vol.28, 2014.
DOI : 10.1523/jneurosci.1900-07.2008

F. Guedj, C. Sébrié, I. Rivals, A. Ledru, E. Paly et al., Green Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A, PLoS ONE, vol.21, issue.25, p.4606, 2009.
DOI : 10.1371/journal.pone.0004606.s001

F. Guedj, P. L. Pereira, S. Najas, M. Barallobre, C. Chabert et al., DYRK1A: A master regulatory protein controlling brain growth, Neurobiology of Disease, vol.46, issue.1, pp.190-203, 2012.
DOI : 10.1016/j.nbd.2012.01.007

S. Guidi, P. Bonasoni, C. Ceccarelli, D. Santini, F. Gualtieri et al., RESEARCH ARTICLE: Neurogenesis Impairment and Increased Cell Death Reduce Total Neuron Number in the Hippocampal Region of Fetuses with Down Syndrome, Brain Pathology, vol.8, issue.2, pp.180-197, 2008.
DOI : 10.1148/radiology.214.2.r00fe40533

L. Guillaud, M. Setou, and N. Hirokawa, KIF17 Dynamics and Regulation of NR2B Trafficking in Hippocampal Neurons, The Journal of Neuroscience, vol.23, issue.1, pp.131-140, 2003.
DOI : 10.1523/JNEUROSCI.23-01-00131.2003

X. Guo, J. G. Williams, T. T. Schug, L. , and X. , DYRK1A and DYRK3 Promote Cell Survival through Phosphorylation and Activation of SIRT1, Journal of Biological Chemistry, vol.5, issue.17, pp.13223-13232, 2010.
DOI : 10.1038/nrc2562

T. Hamada, F. Gejyo, Y. Koshino, T. Murata, M. Omori et al., Echocardiographic Evaluation of Cardiac Valvular Abnormalities in Adults with Down's Syndrome., The Tohoku Journal of Experimental Medicine, vol.185, issue.1, pp.31-35, 1998.
DOI : 10.1620/tjem.185.31

C. Hamilton, Investigation of the articulatory patterns of young adults with Down syndrome using electropalatography, Down Syndrome Research and Practice, vol.1, issue.1, pp.15-28, 1993.
DOI : 10.3104/reports.7

M. Hattori, A. Fujiyama, T. D. Taylor, H. Watanabe, T. Yada et al., The DNA sequence of human chromosome 21, Nature, vol.265, issue.6784, pp.311-319, 2000.
DOI : 10.1126/science.8091227

E. Head and I. T. Lott, Down syndrome and beta-amyloid deposition, Current Opinion in Neurology, vol.17, issue.2, pp.95-100, 2004.
DOI : 10.1097/00019052-200404000-00003

Y. Herault, J. M. Delabar, E. M. Fisher, V. L. Tybulewicz, E. Yu et al., , 2017.

, Rodent models in Down syndrome research: impact and future opportunities, Dis. Model. Mech, vol.10, pp.1165-1186

A. Hestnes, T. Sand, and K. Fostad, Ocular findings in Down's syndrome, Journal of Intellectual Disability Research, vol.25, issue.3, pp.194-203, 1991.
DOI : 10.1111/j.1365-2788.1991.tb01052.x

S. Himpel, W. Tegge, R. Frank, S. Leder, H. Joost et al., Specificity Determinants of Substrate Recognition by the Protein Kinase DYRK1A, Journal of Biological Chemistry, vol.18, issue.4, pp.2431-2438, 2000.
DOI : 10.1016/0076-6879(91)00126-H

S. Himpel, P. Panzer, K. Eirmbter, H. Czajkowska, M. Sayed et al., Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A, Biochemical Journal, vol.359, issue.3, pp.497-505, 2001.
DOI : 10.1042/bj3590497

N. Homma, Y. Takei, Y. Tanaka, T. Nakata, S. Terada et al., Kinesin Superfamily Protein 2A (KIF2A) Functions in Suppression of Collateral Branch Extension, Kinesin Superfamily Protein 2A (KIF2A) Functions in Suppression of Collateral Branch Extension, pp.229-239, 2003.
DOI : 10.1016/S0092-8674(03)00522-1

R. S. Illingworth, CONVULSIONS IN MENTALLY RETARDED CHILDREN WITH OR WITHOUT CEREBRAL PALSY, Journal of Intellectual Disability Research, vol.98, issue.Suppl. III, pp.88-93, 1959.
DOI : 10.1001/jama.1958.03000070024005

A. Inglis, Z. Lohn, J. C. Austin, and C. Hippman, A ???cure??? for Down syndrome: what do parents want?, Clinical Genetics, vol.31, issue.7, pp.310-317, 2014.
DOI : 10.1097/DBP.0b013e3181ee3833

N. Ishizuka, W. M. Cowan, and D. G. Amaral, A quantitative analysis of the dendritic organization of pyramidal cells in the rat hippocampus, The Journal of Comparative Neurology, vol.336, issue.1, pp.17-45, 1995.
DOI : 10.1002/cne.903620103

J. M. Iverson, E. Longobardi, and M. C. Caselli, Relationship between gestures and words in children with Down's syndrome and typically developing children in the early stages of communicative development, International Journal of Language & Communication Disorders, vol.38, issue.2, pp.179-197, 2003.
DOI : 10.1080/1368282031000062891

T. L. Jernigan, U. Bellugi, E. Sowell, S. Doherty, and J. R. Hesselink, Cerebral Morphologic Distinctions Between Williams and Down Syndromes, Archives of Neurology, vol.50, issue.2, pp.186-191, 1993.
DOI : 10.1001/archneur.1993.00540020062019

X. Jiang, C. Liu, T. Yu, L. Zhang, K. Meng et al., Genetic dissection of the Down syndrome critical region, Human Molecular Genetics, vol.42, issue.22, pp.6540-6551, 2015.
DOI : 10.1038/nprot.2006.2

P. Johannsen, J. E. Christensen, H. Goldstein, V. Kamp-nielsen, M. et al., , 1996.

, Epilepsy in Down syndrome?prevalence in three age groups, Seizure, vol.5, pp.121-125

M. Jung, J. Park, Y. S. Ryu, S. Choi, S. Yoon et al., Regulation of RCAN1 Protein Activity by Dyrk1A Protein-mediated Phosphorylation, Journal of Biological Chemistry, vol.87, issue.46, pp.40401-40412, 2011.
DOI : 10.1161/01.RES.87.12.e61

R. Kajiwara, F. G. Wouterlood, A. Sah, A. J. Boekel, B. Bulte et al., Convergence of entorhinal and CA3 inputs onto pyramidal neurons and interneurons in hippocampal area CA1???An anatomical study in the rat, Hippocampus, vol.22, issue.3, pp.266-280, 2008.
DOI : 10.1177/34.10.3745909

P. A. Kelly and Z. Rahmani, DYRK1A Enhances the Mitogen-activated Protein Kinase Cascade in PC12 Cells by Forming a Complex with Ras, B-Raf, and MEK1, Molecular Biology of the Cell, vol.16, issue.8, 2005.
DOI : 10.1074/jbc.M104091200

, Biol. Cell, vol.16, pp.3562-3573

M. B. Kennedy, Signal-Processing Machines at the Postsynaptic Density, Science, vol.290, issue.5492, pp.750-754, 2000.
DOI : 10.1126/science.290.5492.750

N. Khan, F. Afaq, M. Saleem, N. Ahmad, and H. Mukhtar, Targeting Multiple Signaling Pathways by Green Tea Polyphenol (???)-Epigallocatechin-3-Gallate: Figure 1., Cancer Research, vol.66, issue.5, pp.2500-2505, 2006.
DOI : 10.1158/0008-5472.CAN-05-3636

I. Kii, Y. Sumida, T. Goto, R. Sonamoto, Y. Okuno et al., Selective inhibition of the kinase DYRK1A by targeting its folding process, Nature Communications, vol.279, 2016.
DOI : 10.1074/jbc.M314298200

H. Kim, S. O. Sablin, R. , and R. R. , Inhibition of Monoamine Oxidase A by ??-Carboline Derivatives, Archives of Biochemistry and Biophysics, vol.337, issue.1, pp.137-142, 1997.
DOI : 10.1006/abbi.1996.9771

H. Kim, K. Lee, A. Kim, M. Choi, K. Choi et al., A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition, Disease Models & Mechanisms, vol.9, issue.8, pp.839-848, 2016.
DOI : 10.1242/dmm.025668

M. Kim, B. C. Jeong, J. H. Lee, H. J. Kee, H. Kook et al., A repressor complex, AP4 transcription factor and geminin, negatively regulates expression of target genes in nonneuronal cells, Proc. Natl, 2006.
DOI : 10.1101/gad.1319105

, Acad. Sci, vol.103, pp.13074-13079

Y. Kim, J. Park, W. Song, C. , and S. , Overexpression of Dyrk1A Causes the Defects in Synaptic Vesicle Endocytosis, Neurosignals, vol.56, issue.3, pp.164-172, 2010.
DOI : 10.1093/hmg/9.11.1681

R. Kimura, K. Kamino, M. Yamamoto, A. Nuripa, T. Kida et al., The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between ??-amyloid production and tau phosphorylation in Alzheimer disease, Human Molecular Genetics, vol.11, issue.1, pp.15-23, 2007.
DOI : 10.1101/gr.148401

S. M. Kivivuori, J. Rajantie, and M. A. Siimes, Peripheral blood cell counts in infants with Down's syndrome, Clinical Genetics, vol.66, issue.1, pp.15-19, 1996.
DOI : 10.1177/000456329102800405

R. Klink, A. , and A. , Morphological characteristics of layer II projection neurons in the rat medial entorhinal cortex, Hippocampus, vol.3, issue.5, pp.571-583, 1997.
DOI : 10.1002/(SICI)1098-1063(1997)7:5<571::AID-HIPO12>3.0.CO;2-Y

M. Kohansal-nodehi, J. J. Chua, H. Urlaub, R. Jahn, C. et al., Author response image 1. Correlation of phosphosites between biological replicates., eLife, vol.30, 2016.
DOI : 10.7554/eLife.14530.016

B. K. Koo, S. Blaser, D. Harwood-nash, L. E. Becker, M. et al., , 2016.

, Magnetic Resonance Imaging Evaluation of Delayed Myelination in Down Syndrome: A Case Report and Review of the Literature, J. Child Neurol

J. R. Korenberg, H. Kawashima, S. Pulst, T. Ikeuchi, N. Ogasawara et al., Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype, Am. J. Hum. Genet, vol.47, pp.236-246, 1990.

G. Korte, A. Dreiseitel, P. Schreier, A. Oehme, S. Locher et al., Tea catechins??? affinity for human cannabinoid receptors, Phytomedicine, vol.17, issue.1, pp.19-22, 2010.
DOI : 10.1016/j.phymed.2009.10.001

N. Kurabayashi and K. Sanada, Increased dosage of DYRK1A and DSCR1 delays neuronal differentiation in neocortical progenitor cells, Genes & Development, vol.27, issue.24, pp.2708-2721, 2013.
DOI : 10.1101/gad.226381.113

A. Laguna, S. Aranda, M. J. Barallobre, R. Barhoum, E. Fernández et al., The Protein Kinase DYRK1A Regulates Caspase-9-Mediated Apoptosis during Retina Development, Developmental Cell, vol.15, issue.6, pp.841-853, 2008.
DOI : 10.1016/j.devcel.2008.10.014

O. Landry, N. Russo, T. Dawkins, P. D. Zelazo, and J. A. Burack, The Impact of Verbal and Nonverbal Development on Executive Function in Down Syndrome and Williams Syndrome, J. Dev. Disabil, vol.18, 2012.

S. Lanfranchi, C. Cornoldi, and R. Vianello, Verbal and Visuospatial Working Memory Deficits in Children With Down Syndrome, American Journal on Mental Retardation, vol.109, issue.6, 2009.
DOI : 10.1352/0895-8017(2004)109<456:VAVWMD>2.0.CO;2

S. Lanfranchi, O. Jerman, E. Dal-pont, A. Alberti, and R. Vianello, Executive function in adolescents with Down Syndrome, Journal of Intellectual Disability Research, vol.4, issue.4, pp.308-319, 2010.
DOI : 10.1016/S0010-9452(76)80035-4

B. Lange, The Management of Neoplastic Disorders of Haematopoeisis in Children with Down's Syndrome., British Journal of Haematology, vol.19, issue.3, pp.512-524, 2000.
DOI : 10.1016/S0145-2126(98)00016-2

S. Leal-ortiz, C. L. Waites, R. Terry-lorenzo, P. Zamorano, E. D. Gundelfinger et al., Piccolo modulation of Synapsin1a dynamics regulates synaptic vesicle exocytosis, The Journal of Cell Biology, vol.65, issue.5, p.831, 2008.
DOI : 10.1038/nrn1370

Y. Lee, J. Ha, H. J. Kim, Y. Kim, E. Chang et al., , 2009.

, Negative Feedback Inhibition of NFATc1 by DYRK1A Regulates Bone Homeostasis, J. Biol. Chem, vol.284, pp.33343-33351

D. Li, R. A. Jackson, P. Yusoff, and G. R. Guy, Direct Association of Sprouty-related Protein with an EVH1 Domain (SPRED) 1 or SPRED2 with DYRK1A Modifies Substrate/Kinase Interactions, Journal of Biological Chemistry, vol.408, issue.46, pp.35374-35385, 2010.
DOI : 10.1016/S0006-8993(02)04069-6

Z. Li, T. Yu, M. Morishima, A. Pao, J. Laduca et al., Duplication of the entire 22.9??Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities, Human Molecular Genetics, vol.15, issue.11, pp.1359-1366, 2007.
DOI : 10.1002/0471142905.hg0413s46

X. H. Liang, S. Jackson, M. Seaman, K. Brown, B. Kempkes et al., Induction of autophagy and inhibition of tumorigenesis by beclin 1, Nature, vol.8, issue.6762, pp.672-676, 1999.
DOI : 10.1093/nar/25.2.451

G. Liao, D. A. Wagner, M. H. Hsu, L. , and J. P. , -Methyl-d-aspartate Receptor Current, Molecular Pharmacology, vol.59, issue.5, pp.960-964, 2001.
DOI : 10.1124/mol.59.5.960

F. Liu, Z. Liang, J. Wegiel, Y. Hwang, K. Iqbal et al., Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome, The FASEB Journal, vol.22, issue.9, p.3224, 2008.
DOI : 10.1111/j.1742-4658.2006.05217.x

R. Llinás, T. L. Mcguinness, C. S. Leonard, M. Sugimori, and P. Greengard, , 1985.

, Intraterminal injection of synapsin I or calcium/calmodulin-dependent protein kinase II alters neurotransmitter release at the squid giant synapse, Proc. Natl. Acad. Sci. U. S. A, vol.82, p.3035

R. Llinás, J. A. Gruner, M. Sugimori, T. L. Mcguinness, and P. Greengard, , 1991.

, Regulation by synapsin I and Ca(2+)-calmodulin-dependent protein kinase II of the transmitter release in squid giant synapse, J. Physiol, vol.436, p.257

P. A. Lochhead, G. Sibbet, N. Morrice, C. , and V. , Activation-Loop Autophosphorylation Is Mediated by a Novel Transitional Intermediate Form of DYRKs, Cell, vol.121, issue.6, pp.925-936, 2005.
DOI : 10.1016/j.cell.2005.03.034

M. Lu, L. Zheng, B. Han, L. Wang, P. Wang et al., Transcription in a Negative Feedback Loop, Journal of Biological Chemistry, vol.60, issue.12, pp.10755-10763, 2011.
DOI : 10.1006/geno.1999.5998

B. Maenz, P. Hekerman, E. M. Vela, J. Galceran, and W. Becker, Characterization of the human DYRK1A promoter and its regulation by the transcription factor E2F1, BMC Molecular Biology, vol.9, issue.1, p.30, 2008.
DOI : 10.1186/1471-2199-9-30

C. T. Mai, J. E. Kucik, J. Isenburg, M. L. Feldkamp, L. K. Marengo et al., Selected birth defects data from population-based birth defects surveillance programs in the United States, 2006 to 2010: Featuring trisomy conditions, Birth Defects Research Part A: Clinical and Molecular Teratology, vol.15, issue.Pt 1, p.709, 2006.
DOI : 10.1038/gim.2012.93

J. P. Marchal, H. Maurice-stam, B. A. Houtzager, S. L. Rutgers-van-rozenburg-marres, K. J. Oostrom et al., Growing up with Down syndrome: Development from 6 months to 10.7 years, Research in Developmental Disabilities, vol.59, pp.437-450, 2016.
DOI : 10.1016/j.ridd.2016.09.019

J. R. Marland, K. J. Smillie, and M. A. Cousin, Synaptic Vesicle Recycling Is Unaffected in the Ts65Dn Mouse Model of Down Syndrome, PLOS ONE, vol.169, issue.1, 2016.
DOI : 10.1371/journal.pone.0147974.s001

M. Martinez-de-lagran, R. Benavides-piccione, I. Ballesteros-yañez, M. Calvo, M. Morales et al., Dyrk1A Influences Neuronal Morphogenesis Through Regulation of Cytoskeletal Dynamics in Mammalian Cortical Neurons, Cerebral Cortex, vol.276, issue.43, pp.2867-2877, 2012.
DOI : 10.1074/jbc.M104091200

E. Martí, X. Altafaj, M. Dierssen, S. De-la-luna, V. Fotaki et al., Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system, Brain Research, vol.964, issue.2, pp.250-263, 2003.
DOI : 10.1016/S0006-8993(02)04069-6

M. Martí-nez-de-lagrán, X. Altafaj, X. Gallego, E. Martí, X. Estivill et al., Motor phenotypic alterations in TgDyrk1a transgenic mice implicate DYRK1A in Down syndrome motor dysfunction, Neurobiology of Disease, vol.15, issue.1, pp.132-142, 2004.
DOI : 10.1016/j.nbd.2003.10.002

G. Mazzanti, F. Menniti-ippolito, P. A. Moro, F. Cassetti, R. Raschetti et al., Hepatotoxicity from green tea: a review of the literature and two unpublished cases, European Journal of Clinical Pharmacology, vol.20, issue.4, pp.331-341, 2009.
DOI : 10.1177/147323000303100205
URL : https://hal.archives-ouvertes.fr/hal-00534939

K. M. Mcdowell and D. I. Craven, Pulmonary Complications of Down Syndrome during Childhood, The Journal of Pediatrics, vol.158, issue.2, pp.319-325, 2011.
DOI : 10.1016/j.jpeds.2010.07.023

S. D. Mcelyea, J. M. Starbuck, D. M. Tumbleson-brink, E. Harrington, J. D. Blazek et al., Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome, 2016.

, Mol. Genet, vol.25, pp.4856-4869

H. Mclauchlan, M. Elliott, and P. Cohen, The specificities of protein kinase inhibitors: an update, Biochemical Journal, vol.371, issue.1, pp.199-204, 2003.
DOI : 10.1042/bj20021535

M. A. Melyn and D. T. White, MENTAL AND DEVELOPMENTAL MILESTONES OF NONINSTITUTIONALIZED DOWN'S SYNDROME CHILDREN, Pediatrics, vol.52, pp.542-545, 1973.

R. S. Møller, S. Kübart, M. Hoeltzenbein, B. Heye, I. Vogel et al., Truncation of the Down Syndrome Candidate Gene DYRK1A in Two Unrelated Patients with Microcephaly, The American Journal of Human Genetics, vol.82, issue.5, pp.1165-1170, 2008.
DOI : 10.1016/j.ajhg.2008.03.001

H. Monyer, N. Burnashev, D. J. Laurie, B. Sakmann, and P. H. Seeburg, , 1994.

, Developmental and regional expression in the rat brain and functional properties of four NMDA receptors, Neuron, vol.12, pp.529-540

C. A. Moores, J. Cooper, M. Wagenbach, Y. Ovechkina, L. Wordeman et al.,

, The Role of the Kinesin-13 Neck in Microtubule Depolymerization, Cell Cycle

K. Morita, C. L. Celso, B. Spencer-dene, C. C. Zouboulis, and F. M. Watt, HAN11 binds mDia1 and controls GLI1 transcriptional activity, Journal of Dermatological Science, vol.44, issue.1, pp.11-20, 2006.
DOI : 10.1016/j.jdermsci.2006.06.001

D. G. Mumby, S. Gaskin, M. J. Glenn, T. E. Schramek, and H. Lehmann, , 2002.

, Hippocampal Damage and Exploratory Preferences in Rats: Memory for Objects, Places, and Contexts, Learn. Mem, vol.9, p.49

N. Murakami, W. Xie, R. C. Lu, M. Chen-hwang, A. Wieraszko et al.,

, Phosphorylation of Amphiphysin I by Minibrain Kinase/Dual-specificity Tyrosine Phosphorylation-regulated Kinase, a Kinase Implicated in Down Syndrome, J. Biol. Chem, vol.281, pp.23712-23724

N. Murakami, D. C. Bolton, E. Kida, W. Xie, and Y. Hwang, Phosphorylation by Dyrk1A of Clathrin Coated Vesicle-Associated Proteins: Identification of the Substrate Proteins and the Effects of Phosphorylation, PLoS ONE, vol.224, issue.Pt 4, p.34845, 2012.
DOI : 10.1371/journal.pone.0034845.s001

S. K. Murthy, A. K. Malhotra, S. Mani, M. E. Shara, E. E. Al-rowaished et al., Incidence of Down Syndrome in Dubai, UAE, Medical Principles and Practice, vol.36, issue.1, pp.25-28, 2007.
DOI : 10.1016/S0140-6736(71)90287-X

G. Naert, V. Ferré, J. Meunier, E. Keller, S. Malmström et al., Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric A??25???35 peptide administration in mice, European Neuropsychopharmacology, vol.25, issue.11, pp.2170-2182, 2015.
DOI : 10.1016/j.euroneuro.2015.03.018
URL : https://hal.archives-ouvertes.fr/hal-01146496

S. Najas, J. Arranz, P. A. Lochhead, A. L. Ashford, D. Oxley et al., DYRK1A-mediated Cyclin D1 Degradation in Neural Stem Cells Contributes to the Neurogenic Cortical Defects in Down Syndrome. EBioMedicine, pp.120-134, 2015.

L. Nelson, J. K. Johnson, M. Freedman, I. Lott, J. Groot et al., Learning and memory as a function of age in Down syndrome: A study using animal-based tasks, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.29, issue.3, pp.443-453, 2005.
DOI : 10.1016/j.pnpbp.2004.12.009

T. Nguyen, D. Giovanni, and S. , NFAT signaling in neural development and axon growth, International Journal of Developmental Neuroscience, vol.26, issue.2, pp.141-145, 2008.
DOI : 10.1016/j.ijdevneu.2007.10.004

T. L. Nguyen, C. Fruit, Y. Hérault, L. Meijer, and T. Besson, Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors: a survey of recent patent literature, Expert Opinion on Therapeutic Patents, vol.19, issue.11, pp.1-17, 2017.
DOI : 10.1016/S1474-4422(16)30034-5
URL : https://hal.archives-ouvertes.fr/hal-02046302

R. Oegema, A. Klein, . De, A. J. Verkerk, R. Schot et al., Distinctive Phenotypic Abnormalities Associated with Submicroscopic 21q22 Deletion Including DYRK1A, Molecular Syndromology, vol.1, issue.3, p.113, 2010.
DOI : 10.1159/000320113

T. Ogawa and N. Hirokawa, Microtubule Destabilizer KIF2A Undergoes Distinct Site-Specific Phosphorylation Cascades that Differentially Affect Neuronal Morphogenesis, Cell Reports, vol.12, issue.11, pp.1774-1788, 2015.
DOI : 10.1016/j.celrep.2015.08.018

Y. Ogawa, Y. Nonaka, T. Goto, E. Ohnishi, T. Hiramatsu et al., Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A, Nature Communications, vol.27, issue.7, 1090.
DOI : 10.1042/bj3550609

B. Oliver and S. Buckley, The language development of children with Down syndrome: First words to two-word phrases, Syndr. Res. Pract, vol.2, pp.71-75, 1994.

C. Oliver, L. Crayton, A. Holland, and J. Bradbury, A four year prospective study of age-related cognitive change in adults with Down's syndrome, Psychological Medicine, vol.28, issue.6, 1998.
DOI : 10.1017/S0033291798007417

J. L. Olmos-serrano, W. A. Tyler, H. J. Cabral, and T. F. Haydar, Longitudinal measures of cognition in the Ts65Dn mouse: Refining windows and defining modalities for therapeutic intervention in Down syndrome, Experimental Neurology, vol.279, pp.40-56, 2016.
DOI : 10.1016/j.expneurol.2016.02.005

L. E. Olson, R. J. Roper, L. Baxter, and E. Carlson, , 2004.

, Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes, Dev. Dyn, vol.230, pp.581-589

K. M. Ori-mckenney, R. J. Mckenney, H. H. Huang, T. Li, S. Meltzer et al., Phosphorylation of ??-Tubulin by the Down Syndrome Kinase, Minibrain/DYRK1a, Regulates Microtubule Dynamics and Dendrite Morphogenesis, Neuron, vol.90, issue.3, pp.551-563, 2016.
DOI : 10.1016/j.neuron.2016.03.027

J. Park, Y. Oh, L. Yoo, M. Jung, W. Song et al.,

, Dyrk1A Phosphorylates p53 and Inhibits Proliferation of Embryonic Neuronal Cells

, J. Biol. Chem, vol.285, pp.31895-31906

J. Park, J. Y. Sung, J. Park, W. Song, S. Chang et al., Dyrk1A negatively regulates the actin cytoskeleton through threonine phosphorylation of N-WASP, Journal of Cell Science, vol.125, issue.1, pp.67-80, 2012.
DOI : 10.1242/jcs.086124

S. E. Parker, C. T. Mai, M. A. Canfield, R. Rickard, Y. Wang et al., Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006, Birth Defects Research Part A: Clinical and Molecular Teratology, vol.146, issue.Suppl 2, pp.1008-1016, 2004.
DOI : 10.1001/archpedi.1992.02160190089028

J. D. Pinter, S. Eliez, J. E. Schmitt, G. T. Capone, and A. L. Reiss, Neuroanatomy of Down???s Syndrome: A High-Resolution MRI Study, American Journal of Psychiatry, vol.158, issue.10, 2001.
DOI : 10.1176/appi.ajp.158.10.1659

M. Pons-espinal, M. Martinez-de-lagran, and M. Dierssen, Environmental enrichment rescues DYRK1A activity and hippocampal adult neurogenesis in TgDyrk1A, Neurobiology of Disease, vol.60, pp.18-31, 2013.
DOI : 10.1016/j.nbd.2013.08.008

V. P. Prasher, Epilepsy and associated effects on adaptive behaviour in adults with Down syndrome, Seizure, vol.4, issue.1, pp.53-56, 1995.
DOI : 10.1016/S1059-1311(05)80079-2

M. Rachidi and C. Lopes, Mental retardation and associated neurological dysfunctions in Down syndrome: A consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways, European Journal of Paediatric Neurology, vol.12, issue.3, pp.168-182, 2008.
DOI : 10.1016/j.ejpn.2007.08.010

Z. Rahmani, J. L. Blouin, N. Creau-goldberg, P. C. Watkins, J. F. Mattei et al., Critical role of the D21S55 region on chromosome 21 in the pathogenesis of Down syndrome., Proc. Natl. Acad. Sci. U. S. A. 86, p.5958, 1989.
DOI : 10.1073/pnas.86.15.5958

B. Ravikumar, R. Duden, and D. C. And-rubinsztein, Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy, Human Molecular Genetics, vol.11, issue.9, pp.1107-1117, 2002.
DOI : 10.1093/hmg/11.9.1107

R. H. Reeves, N. G. Irving, T. H. Moran, A. Wohn, C. Kitt et al., A mouse model for Down syndrome exhibits learning and behaviour deficits, Nature Genetics, vol.5, issue.2, pp.177-184, 1995.
DOI : 10.1016/0092-8674(86)90493-9

L. G. Reinholdt, Y. Ding, G. T. Gilbert, A. Czechanski, J. P. Solzak et al., Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn, Mammalian Genome, vol.19, issue.11-12, pp.685-691, 2011.
DOI : 10.1101/gr.073585.107

S. O. Rizzoli, Synaptic vesicle recycling: steps and principles, The EMBO Journal, vol.33, issue.8, pp.788-822, 2014.
DOI : 10.1002/embj.201386357

N. J. Roizen and A. P. Amarose, Hematologic abnormalities in children with down syndrome, American Journal of Medical Genetics, vol.3, issue.5, pp.510-512, 1993.
DOI : 10.1111/j.1600-0609.1973.tb00108.x

N. J. Roizen, C. Wolters, T. Nicol, and T. A. Blondis, Hearing loss in children with Down syndrome, The Journal of Pediatrics, vol.123, issue.1, pp.9-12, 1993.
DOI : 10.1016/S0022-3476(05)81588-4

N. J. Roizen, M. B. Mets, and T. A. Blondis, OPHTHALMIC DISORDERS IN CHILDREN WITH DOWN SYNDROME. Dev. Med. Amp Child Neurol, vol.36, pp.594-600, 1994.

A. Ronan, K. Fagan, L. Christie, J. Conroy, N. J. Nowak et al., Findings that shed new light on the possible pathogenesis of a disease or an adverse effect: Familial 4, 2009.

, Mb duplication of 21q22 sheds new light on the Down syndrome critical region, BMJ Case Rep, 2009.

J. Rondal and A. Comblain, Language in adults with Down syndrome, Syndr. Res. Pract, vol.4, pp.3-14, 1996.

R. Roskoski, A historical overview of protein kinases and their targeted small molecule inhibitors, Pharmacological Research, vol.100, pp.1-23, 2015.
DOI : 10.1016/j.phrs.2015.07.010

T. Rousseau, E. Amar, C. Ferdynus, C. Thauvin-robinet, J. Gouyon et al., Variations de prévalence de la trisomie 21 en population française entre, 1978.

, J. Gynécologie Obstétrique Biol. Reprod, vol.39, pp.290-296

J. Rowe, A. Lavender, and V. Turk, Cognitive executive function in Down's syndrome, British Journal of Clinical Psychology, vol.7, issue.Supplement, pp.5-17, 2006.
DOI : 10.1001/archneur.1992.00530280101029

Y. S. Ryu, S. Y. Park, M. Jung, S. Yoon, M. Kwen et al., Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer???s disease, Journal of Neurochemistry, vol.2, issue.3, pp.574-584, 2010.
DOI : 10.1007/978-3-7091-6721-2_12

H. Sago, E. J. Carlson, D. J. Smith, J. Kilbridge, E. M. Rubin et al., Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities, Proc. Natl. Acad. Sci. 95, pp.6256-6261, 1998.
DOI : 10.1038/39315

M. W. Salter and L. V. Kalia, Src kinases: a hub for NMDA receptor regulation, Nature Reviews Neuroscience, vol.276, issue.4, pp.317-328, 2004.
DOI : 10.1074/jbc.M103501200

T. M. Scales, S. Lin, M. Kraus, R. G. Goold, and P. R. Gordon-weeks, Nonprimed and DYRK1A-primed GSK3??-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons, Journal of Cell Science, vol.122, issue.14, pp.2424-2435, 2009.
DOI : 10.1242/jcs.040162

J. D. Schmahmann and J. C. Sherman, Cerebellar Cognitive Affective Syndrome, Int. Rev. Neurobiol, vol.41, pp.433-440, 1997.
DOI : 10.1016/S0074-7742(08)60363-3

A. Seifert, L. A. Allan, C. , and P. R. , DYRK1A phosphorylates caspase 9 at an inhibitory site and is potently inhibited in human cells by harmine, FEBS Journal, vol.355, issue.24, pp.6268-6280, 2008.
DOI : 10.1042/bj3550597

J. Shi, T. Zhang, C. Zhou, M. O. Chohan, X. Gu et al., Increased Dosage of Dyrk1A Alters Alternative Splicing Factor (ASF)-regulated Alternative Splicing of Tau in Down Syndrome, Journal of Biological Chemistry, vol.12, issue.42, pp.28660-28669, 2008.
DOI : 10.1038/nsmb1209

S. R. Shott, A. Joseph, and D. Heithaus, Hearing loss in children with Down syndrome, International Journal of Pediatric Otorhinolaryngology, vol.61, issue.3, pp.199-205, 2001.
DOI : 10.1016/S0165-5876(01)00572-9

R. J. Siarey, A. J. Villar, C. J. Epstein, and Z. Galdzicki, Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome, Neuropharmacology, vol.49, issue.1, pp.122-128, 2005.
DOI : 10.1016/j.neuropharm.2005.02.012

A. V. Skurat and A. D. Dietrich, in Muscle Glycogen Synthase by DYRK Family Protein Kinases, Journal of Biological Chemistry, vol.60, issue.4, pp.2490-2498, 2004.
DOI : 10.1101/gad.884001

D. J. Smith, Y. Zhu, J. Zhang, J. Cheng, R. et al., Construction of a Panel of Transgenic Mice Containing a Contiguous 2-Mb Set of YAC/P1 Clones from Human Chromosome 21q22.2, Genomics, vol.27, issue.3, pp.425-434, 1995.
DOI : 10.1006/geno.1995.1073

D. J. Smith, M. E. Stevens, S. P. Sudanagunta, R. T. Bronson, M. Makhinson et al., Functional screening, 1997.

, Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome, Nat. Genet, vol.16, pp.28-36

U. Soppa, J. Schumacher, V. F. Ortiz, T. Pasqualon, F. Tejedor et al., , 2014.

, The Down syndrome-related protein kinase DYRK1A phosphorylates p27Kip1 and Cyclin D1 and induces cell cycle exit and neuronal differentiation, Cell Cycle

B. Souchet, F. Guedj, I. Sahún, A. Duchon, F. Daubigney et al., Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage, Neurobiology of Disease, vol.69, pp.65-75, 2014.
DOI : 10.1016/j.nbd.2014.04.016

N. Spruston, Pyramidal neurons: dendritic structure and synaptic integration, Nature Reviews Neuroscience, vol.27, issue.3, pp.206-221, 2008.
DOI : 10.1038/nn0705-839

F. Stagni, A. Giacomini, M. Emili, S. Trazzi, S. Guidi et al., Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome, Neuroscience, vol.333, pp.277-301, 2016.
DOI : 10.1016/j.neuroscience.2016.07.031

J. M. Starbuck, T. Dutka, T. S. Ratliff, R. H. Reeves, and R. , J.T, 2014.

, Overlapping trisomies for human chromosome 21 orthologs produce similar effects on skull and brain morphology of Dp(16)1Yey and Ts65Dn mice, Am. J. Med. Genet. A, vol.164, pp.1981-1990

M. Stringer, I. Abeysekera, K. J. Dria, R. J. Roper, and C. R. Goodlett, Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model, Pharmacology Biochemistry and Behavior, vol.138, pp.70-79, 2015.
DOI : 10.1016/j.pbb.2015.09.002

M. Stringer, I. Abeysekera, J. Thomas, J. Lacombe, K. Stancombe et al., Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes, Physiology & Behavior, vol.177, pp.230-241, 2017.
DOI : 10.1016/j.physbeh.2017.05.003

R. Sureshbabu, R. Kumari, S. Ranugha, R. Sathyamoorthy, C. Udayashankar et al., Phenotypic and dermatological manifestations in Down Syndrome, Dermatol. Online J, vol.17, 2011.

T. Tahtouh, J. M. Elkins, P. Filippakopoulos, M. Soundararajan, G. Burgy et al., Selectivity, Cocrystal Structures, and Neuroprotective Properties of Leucettines, a Family of Protein Kinase Inhibitors Derived from the Marine Sponge Alkaloid Leucettamine B, Journal of Medicinal Chemistry, vol.55, issue.21, pp.9312-9330, 2012.
DOI : 10.1021/jm301034u
URL : https://hal.archives-ouvertes.fr/hal-00870472

S. Takashima, K. Iida, T. Mito, and M. Arima, Dendritic and histochemical development and ageing in patients with Down's syndrome, Journal of Intellectual Disability Research, vol.35, issue.3, pp.265-273, 1994.
DOI : 10.1212/WNL.35.7.957

T. Adayev, ?. Mo-chou-chen-hwang, ?. , N. Murakami, ?. et al., Kinetic Properties of a MNB, 2006.

F. Tejedor, X. R. Zhu, E. Kaltenbach, A. Ackermann, A. Baumann et al., minibrain: A new protein kinase family involved in postembryonic neurogenesis in Drosophila, Neuron, vol.14, issue.2, pp.287-301, 1995.
DOI : 10.1016/0896-6273(95)90286-4

K. Thomas, J. Bourke, S. Girdler, A. Bebbington, P. Jacoby et al., , 2011.

, Variation Over Time in Medical Conditions and Health Service Utilization of Children with Down Syndrome, J. Pediatr, vol.158, pp.194-200

A. Thomazeau, O. Lassalle, J. Iafrati, B. Souchet, F. Guedj et al., Prefrontal Deficits in a Murine Model Overexpressing the Down Syndrome Candidate Gene Dyrk1a, Journal of Neuroscience, vol.34, issue.4, pp.1138-1147, 2014.
DOI : 10.1523/JNEUROSCI.2852-13.2014

R. Torre, S. Sola, M. Pons, A. Duchon, M. M. Lagran et al., Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans, Molecular Nutrition & Food Research, vol.7, issue.2, pp.278-288, 2014.
DOI : 10.1089/ars.2005.7.1704

R. Torre, . De-la, S. Sola, . De, G. Hernandez et al., Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial, The Lancet Neurology, vol.15, issue.8, pp.801-810, 2016.
DOI : 10.1016/S1474-4422(16)30034-5

R. Tsao and D. Mellier, ??tude des??habilet??s graphomotrices chez??l'enfant et??l'adulte porteurs de??trisomie 21??: approche d??veloppementale et??comparative, Neuropsychiatrie de l'Enfance et de l'Adolescence, vol.53, issue.8, 2005.
DOI : 10.1016/j.neurenf.2005.09.016

, Enfance Adolesc, vol.53, pp.401-406

A. Valetto, A. Orsini, V. Bertini, B. Toschi, A. Bonuccelli et al., Molecular cytogenetic characterization of an interstitial deletion of chromosome 21 (21q22.13q22.3) in a patient with dysmorphic features, intellectual disability and severe generalized epilepsy, European Journal of Medical Genetics, vol.55, issue.5, pp.362-366, 2012.
DOI : 10.1016/j.ejmg.2012.03.011

S. Vicari, Motor Development and Neuropsychological Patterns in Persons with Down Syndrome, Behavior Genetics, vol.7, issue.3, pp.355-364, 2006.
DOI : 10.1017/S1355617704106073

S. Vicari, M. C. Caselli, and F. Tonucci, Asynchrony of lexical and morphosyntactic development in children with Down Syndrome, Neuropsychologia, vol.38, issue.5, pp.634-644, 2000.
DOI : 10.1016/S0028-3932(99)00110-4

S. Vicari, E. Bates, M. C. Caselli, P. Pasqualetti, C. Gagliardi et al., Neuropsychological profile of Italians with Williams syndrome: An example of a dissociation between language and cognition?, Journal of the International Neuropsychological Society, vol.22, issue.06, 2004.
DOI : 10.1017/S1355617701744086

C. L. Waites, S. A. Leal-ortiz, T. F. Andlauer, S. J. Sigrist, and C. C. Garner, , 2011.

, Piccolo regulates the dynamic assembly of presynaptic F-actin, J. Neurosci. Off. J. Soc. Neurosci, p.31, 14250.

A. Walte, K. Rüben, R. Birner?gruenberger, C. Preisinger, S. Bamberg?lemper et al., Mechanism of dual specificity kinase activity of DYRK1A, FEBS Journal, vol.283, issue.18, pp.4495-4511, 2013.
DOI : 10.1074/jbc.M804970200

J. Wegiel, I. Kuchna, K. Nowicki, J. Frackowiak, K. Dowjat et al., Cell type- and brain structure-specific patterns of distribution of minibrain kinase in human brain, Brain Research, vol.1010, issue.1-2, pp.69-80, 2004.
DOI : 10.1016/j.brainres.2004.03.008

J. Wegiel, C. Gong, and Y. Hwang, The role of DYRK1A in neurodegenerative diseases, FEBS Journal, vol.25, issue.2, pp.236-245, 2011.
DOI : 10.1523/JNEUROSCI.1521-05.2005

R. I. Wilson and R. A. Nicoll, Endocannabinoid Signaling in the Brain, Science, vol.296, issue.5568, pp.678-682, 2002.
DOI : 10.1126/science.1063545

K. E. Wisniewski, Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis, American Journal of Medical Genetics, vol.8, issue.S7, pp.274-281, 1990.
DOI : 10.1212/WNL.34.7.909

M. P. Witter and D. G. Amaral, Entorhinal cortex of the monkey: V. Projections to the dentate gyrus, hippocampus, and subicular complex, The Journal of Comparative Neurology, vol.199, issue.3, pp.437-459, 1991.
DOI : 10.1177/24.12.63512

Y. L. Woods, G. Rena, N. Morrice, A. Barthel, W. Becker et al., The kinase DYRK1A phosphorylates the transcription factor FKHR at Ser329 in vitro, a novel in vivo phosphorylation site, Biochemical Journal, vol.355, issue.3, pp.597-607, 2001.
DOI : 10.1042/bj3550597

Y. L. Woods, P. Cohen, W. Becker, R. Jakes, M. Goedert et al., The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2B?? at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase, Biochemical Journal, vol.355, issue.3, pp.609-615, 2001.
DOI : 10.1042/bj3550609

P. Wu, T. E. Nielsen, and M. H. Clausen, FDA-approved small-molecule kinase inhibitors, Trends in Pharmacological Sciences, vol.36, issue.7, pp.422-439, 2015.
DOI : 10.1016/j.tips.2015.04.005

P. Wu, T. E. Nielsen, and M. H. Clausen, Small-molecule kinase inhibitors: an analysis of FDA-approved drugs, Drug Discovery Today, vol.21, issue.1, pp.5-10, 2016.
DOI : 10.1016/j.drudis.2015.07.008

O. Yabut, J. Domogauer, D. Arcangelo, and G. , Dyrk1A Overexpression Inhibits Proliferation and Induces Premature Neuronal Differentiation of Neural Progenitor Cells, Journal of Neuroscience, vol.30, issue.11, pp.4004-4014, 2010.
DOI : 10.1523/JNEUROSCI.4711-09.2010

T. Yamamoto, K. Shimojima, T. Nishizawa, M. Matsuo, M. Ito et al., , 2011.

, Clinical manifestations of the deletion of Down syndrome critical region including DYRK1A and KCNJ6, Am. J. Med. Genet. A, vol.155, pp.113-119

C. S. Yang, X. Wang, G. Lu, and S. C. Picinich, Cancer prevention by tea: animal studies, molecular mechanisms and human relevance, Nature Reviews Cancer, vol.14, issue.6, pp.429-439, 2009.
DOI : 10.3748/wjg.v13.i8.1162

Q. Yang, S. A. Rasmussen, and J. Friedman, Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study, The Lancet, vol.359, issue.9311, pp.1019-1025, 2002.
DOI : 10.1016/S0140-6736(02)08092-3

W. Yu and E. Krook-magnuson, Cognitive Collaborations: Bidirectional Functional Connectivity Between the Cerebellum and the Hippocampus, Frontiers in Systems Neuroscience, vol.54, issue.35, 2015.
DOI : 10.1016/j.neuron.2007.06.003

T. Yu, C. Liu, P. Belichenko, S. J. Clapcote, S. Li et al., Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice, Brain Research, vol.1366, pp.162-171, 2010.
DOI : 10.1016/j.brainres.2010.09.107

Y. Huang, ?. Mo-chou-chen-hwang, ?. , G. Dolios, ?. et al.,

?. Padovan, R. Wang, Y. Hwang, *. , and ?. , Mnb/Dyrk1A Phosphorylation Regulates the Interaction of Dynamin 1 with SH3 Domain-Containing Proteins ?, 2004.

D. A. Zachor, E. Mroczek-musulman, and P. Brown, Prevalence of Celiac Disease in Down Syndrome in the United States, Journal of Pediatric Gastroenterology and Nutrition, vol.31, issue.3, pp.275-279
DOI : 10.1097/00005176-200009000-00014

Y. Zou, S. Lim, K. Lee, X. Deng, and E. Friedman, Serine/Threonine Kinase Mirk/Dyrk1B Is an Inhibitor of Epithelial Cell Migration and Is Negatively Regulated by the Met Adaptor Ran-binding Protein M, Journal of Biological Chemistry, vol.16, issue.49, pp.49573-49581, 2003.
DOI : 10.1074/jbc.M104091200